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Abstract: Lipid-core plaque (LCP) detected by intracoronary near-infrared spectroscopy (NIRS) is associated with acute coronary syndromes and 
predicts complications during coronary stenting. To our knowledge, NIRS has never been applied in the carotid arteries and it is unknown whether 
NIRS can detect carotid LCP. This study was performed to demonstrate the feasibility of NIRS in the carotid arteries.
Methods: NIRS was performed in the carotid arteries of patients with severe carotid stenosis after distal filter placement but prior to stenting. LCP 
at the stenosis site was quantified by the lipid-core burden index (LCBI) and the maximum LCBI in any 4-mm segment (maxLCBI4mm). The LCBI is 
defined as the fraction of pixels indicating lipid multiplied by 1000.
results: We performed NIRS imaging in the carotid arteries of 2 symptomatic and 8 asymptomatic patients (age 67 ± 12). There were no 
neurological complications. Both symptomatic patients and 5 of 8 asymptomatic patients had LCP in the carotid artery by NIRS. Among the 7 
patients with LCP, the LCBI and maxLCBI4mm were 229 ±136 and 340 ± 169, respectively. After stenting, NIRS often demonstrated a reduction in 
lipid content (Figure).
conclusion: We describe first-in-man use of NIRS imaging within the carotid arteries and demonstrate its feasibility. Future studies are needed to 
determine if NIRS can determine the risk of stent-related complications, influence the selection of patients for stenting or endarterectomy, or predict 
future neurologic events.
 
